🇺🇸 FDA
Patent

US 8404817

Humanized anti-prostate stem cell antigen monoclonal antibody

granted A61KA61K2039/505

Quick answer

US patent 8404817 (Humanized anti-prostate stem cell antigen monoclonal antibody) held by The Regents of the University of California expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505